{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:40:41Z","timestamp":1787928041730,"version":"build-2784847793"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-023-05204-9","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T02:01:27Z","timestamp":1695348087000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Management of Blau syndrome: review and proposal of a treatment algorithm"],"prefix":"10.1007","volume":"183","author":[{"given":"Hanene","family":"Lassoued Ferjani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0900-5516","authenticated-orcid":false,"given":"Lobna","family":"Kharrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorra","family":"Ben Nessib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhia","family":"Kaffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaouther","family":"Maatallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"issue":"2","key":"5204_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11882-021-00991-3","volume":"21","author":"KP Kaufman","year":"2021","unstructured":"Kaufman KP, Becker ML (2021) Distinguishing Blau syndrome from systemic sarcoidosis. Curr Allergy Asthma Rep 21(2):10","journal-title":"Curr Allergy Asthma Rep"},{"issue":"5","key":"5204_CR2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.23736\/S0392-0488.19.06524-6","volume":"155","author":"S Takada","year":"2020","unstructured":"Takada S, Saito MK, Kambe N (2020) Blau syndrome: NOD2-related systemic autoinflammatory granulomatosis. G Ital Dermatol Venereol 155(5):537\u2013541","journal-title":"G Ital Dermatol Venereol"},{"issue":"4","key":"5204_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/diagnostics9040160","volume":"9","author":"B Chiu","year":"2019","unstructured":"Chiu B, Chan J, Das S, Alshamma Z, Sergi C (2019) Pediatric sarcoidosis: a review with emphasis on early onset and high-risk sarcoidosis and diagnostic challenges. Diagnostics (Basel) 9(4):160","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"5204_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.autrev.2012.07.028","volume":"12","author":"P Sfriso","year":"2012","unstructured":"Sfriso P, Caso F, Tognon S, Galozzi P, Gava A, Punzi L (2012) Blau syndrome, clinical and genetic aspects. Autoimmun Rev 12(1):44\u201351","journal-title":"Autoimmun Rev"},{"issue":"2","key":"5204_CR5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jaapos.2019.12.008","volume":"24","author":"A Sidiqi","year":"2020","unstructured":"Sidiqi A, Pegado V (2020) Blau syndrome following a bacterial infection. J AAPOS 24(2):118\u2013120","journal-title":"J AAPOS"},{"issue":"1","key":"5204_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12969-021-00505-5","volume":"19","author":"F Okazaki","year":"2021","unstructured":"Okazaki F, Wakiguchi H, Korenaga Y, Nakamura T, Yasudo H, Uchi S et al (2021) A novel mutation in early-onset sarcoidosis\/Blau syndrome: an association with Propionibacterium acnes. Pediatr Rheumatol Online J 19(1):18","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"5204_CR7","first-page":"117","volume":"8","author":"A Arakawa","year":"2021","unstructured":"Arakawa A, Kambe N, Nishikomori R, Tanabe A, Ueda M, Nishigori C et al (2021) NOD2 mutation-associated case with Blau syndrome triggered by BCG vaccination. Children (Basel) 8(2):117","journal-title":"Children (Basel)"},{"issue":"6","key":"5204_CR8","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1093\/rheumatology\/keu437","volume":"54","author":"CD Ros\u00e9","year":"2015","unstructured":"Ros\u00e9 CD, Pans S, Casteels I, Anton J, Bader-Meunier B, Brissaud P et al (2015) Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes. Rheumatology (Oxford) 54(6):1008\u20131016","journal-title":"Rheumatology (Oxford)"},{"key":"5204_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jpeds.2020.01.057","volume":"221","author":"J Poline","year":"2020","unstructured":"Poline J, Bourrat E, Meinzer U (2020) Camptodactlyly in pediatric practice: Blau syndrome. J Pediatr 221:257\u2013259","journal-title":"J Pediatr"},{"issue":"2","key":"5204_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/jdv.15963","volume":"34","author":"J Poline","year":"2020","unstructured":"Poline J, Fogel O, Pajot C, Miceli-Richard C, Rybojad M, Galeotti C et al (2020) Early-onset granulomatous arthritis, uveitis and skin rash: characterization of skin involvement in Blau syndrome. J Eur Acad Dermatol Venereol 34(2):340\u2013348","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"5204_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102944","volume":"20","author":"I Maccora","year":"2021","unstructured":"Maccora I, Marrani E, Mastrolia MV, Abu-Rumeileh S, Maniscalco V, Fusco E et al (2021) Ocular involvement in monogenic autoinflammatory disease. Autoimmun Rev 20(11):102944","journal-title":"Autoimmun Rev"},{"issue":"2","key":"5204_CR12","first-page":"396","volume":"23","author":"SK Saini","year":"1996","unstructured":"Saini SK, Rose CD (1996) Liver involvement in familial granulomatous arthritis (Blau syndrome). J Rheumatol 23(2):396\u2013399","journal-title":"J Rheumatol"},{"issue":"3","key":"5204_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0022-3476(98)70286-0","volume":"133","author":"SS Ting","year":"1998","unstructured":"Ting SS, Ziegler J, Fischer E (1998) Familial granulomatous arthritis (Blau syndrome) with granulomatous renal lesions. J Pediatr 133(3):450\u2013452","journal-title":"J Pediatr"},{"issue":"5","key":"5204_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/0002-9343(85)90286-4","volume":"78","author":"DA Jabs","year":"1985","unstructured":"Jabs DA, Houk JL, Bias WB, Arnett FC (1985) Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med 78(5):801\u2013804","journal-title":"Am J Med"},{"key":"5204_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2021.101378","volume":"65","author":"R Sinharay","year":"2021","unstructured":"Sinharay R, McKeown L, Phillips C, Li A, Duckworth A, Hall F et al (2021) First report of liver transplantation in Blau syndrome: the challenges faced in this rare granulomatous liver disease. Transpl Immunol 65:101378","journal-title":"Transpl Immunol"},{"issue":"1","key":"5204_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10067-017-3758-7","volume":"37","author":"D Wu","year":"2018","unstructured":"Wu D, Shen M (2018) Two Chinese pedigrees of Blau syndrome with thirteen affected members. Clin Rheumatol 37(1):265\u2013270","journal-title":"Clin Rheumatol"},{"issue":"2","key":"5204_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/ajd.13551","volume":"62","author":"J Su","year":"2021","unstructured":"Su J, Liu D (2021) Blau syndrome with pulmonary nodule in a child. Australas J Dermatol 62(2):217\u2013220","journal-title":"Australas J Dermatol"},{"key":"5204_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ajo.2017.08.017","volume":"187","author":"IL Sarens","year":"2018","unstructured":"Sarens IL, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Ch\u00e9deville G et al (2018) Blau Syndrome-associated uveitis: preliminary results from an international prospective interventional case series. Am J Ophthalmol 187:158\u2013166","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"5204_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/09273948.2019.1569239","volume":"28","author":"S Wu","year":"2020","unstructured":"Wu S, Zhong L, Sun Z, Zhu T, Song H, Sui R (2020) Ocular features in Chinese patients with Blau syndrome. Ocul Immunol Inflamm 28(1):79\u201385","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"5204_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12969-021-00633-y","volume":"19","author":"S Iriqat","year":"2021","unstructured":"Iriqat S, Safieh MA, Fatouleh M, Alkaiyat A (2021) Blau syndrome: a case report from Palestine. Pediatr Rheumatol Online J 19(1):138","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"5204_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00296-019-04316-6","volume":"41","author":"AK Jindal","year":"2021","unstructured":"Jindal AK, Pilania RK, Suri D, Gupta A, Gattorno M, Ceccherini I et al (2021) A young female with early onset arthritis, uveitis, hepatic, and renal granulomas: a clinical tryst with Blau syndrome over 20 years and case-based review. Rheumatol Int 41(1):173\u2013181","journal-title":"Rheumatol Int"},{"key":"5204_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.895765","volume":"13","author":"T Matsuda","year":"2022","unstructured":"Matsuda T, Kambe N, Takimoto-Ito R, Ueki Y, Nakamizo S, Saito MK et al (2022) Potential benefits of TNF targeting therapy in Blau syndrome, a NOD2-associated systemic autoinflammatory granulomatosis. Front Immunol 13:895765","journal-title":"Front Immunol"},{"issue":"1","key":"5204_CR23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3928\/23258160-20171215-12","volume":"49","author":"H Nascimento","year":"2018","unstructured":"Nascimento H, Sousa JM, Fern\u00e1ndez DG, Salom\u00e3o GHA, Sato EH, Muccioli C et al (2018) Blau-Jabs syndrome in a tertiary ophthalmologic center. Ophthalmic Surg Lasers Imaging Retina 49(1):70\u201375","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"5204_CR24","doi-asserted-by":"crossref","unstructured":"Mar\u00edn-Noriega MA, Mu\u00f1oz-Ortiz J, Mosquera C, de-la-Torre A (2020) Ophthalmological treatment of early-onset sarcoidosis\/Blau syndrome in a Colombian child: a case report. Am J Ophthalmol Case Rep 18:100714","DOI":"10.1016\/j.ajoc.2020.100714"},{"key":"5204_CR25","doi-asserted-by":"crossref","unstructured":"Pa\u00c7 Kisaarslan A, S\u00d6zer\u0130 B, \u015eah\u0130n N, \u00d6zdem\u0130r \u00c7\u0130\u00c7ek S, G\u00dcnd\u00dcz Z, Dem\u0130rkaya E et al (2020) Blau syndrome and early-onset sarcoidosis: a six case series and review of the literature. Arch Rheumatol 35(1):117\u2013127","DOI":"10.5606\/ArchRheumatol.2020.7060"},{"issue":"12","key":"5204_CR26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1177\/000992289803701201","volume":"37","author":"AK Shetty","year":"1998","unstructured":"Shetty AK, Gedalia A (1998) Sarcoidosis: a pediatric perspective. Clin Pediatr (Phila) 37(12):707\u2013717","journal-title":"Clin Pediatr (Phila)"},{"issue":"7","key":"5204_CR27","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/ced.14016","volume":"44","author":"GWM Millington","year":"2019","unstructured":"Millington GWM, Dobson J, Holden S, Waters G, Puvanachandra N, Close R et al (2019) Sporadic Blau syndrome treated with adalimumab. Clin Exp Dermatol 44(7):811\u2013813","journal-title":"Clin Exp Dermatol"},{"key":"5204_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.932919","volume":"13","author":"R Kumrah","year":"2022","unstructured":"Kumrah R, Pilania RK, Menia NK, Rawat A, Sharma J, Gupta A et al (2022) Blau syndrome: lessons learned in a tertiary care centre at Chandigarh. North India Front Immunol 13:932919","journal-title":"North India Front Immunol"},{"issue":"1","key":"5204_CR29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s13075-019-2017-5","volume":"21","author":"J Chen","year":"2019","unstructured":"Chen J, Luo Y, Zhao M, Wu D, Yang Y, Zhang W et al (2019) Effective treatment of TNF\u03b1 inhibitors in Chinese patients with Blau syndrome. Arthritis Res Ther 21(1):236","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"5204_CR30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/art.25035","volume":"62","author":"K Yasui","year":"2010","unstructured":"Yasui K, Yashiro M, Tsuge M, Manki A, Takemoto K, Yamamoto M et al (2010) Thalidomide dramatically improves the symptoms of early-onset sarcoidosis\/Blau syndrome: its possible action and mechanism. Arthritis Rheum 62(1):250\u2013257","journal-title":"Arthritis Rheum"},{"issue":"7","key":"5204_CR31","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.21037\/apm-21-2216","volume":"11","author":"W Wang","year":"2022","unstructured":"Wang W, Wang W, Zhong LQ, Li WD, Wu SJ, Song HM (2022) Thalidomide may be an effective drug for Blau syndrome: a case report. Ann Palliat Med 11(7):2538\u20132543","journal-title":"Ann Palliat Med"},{"issue":"4","key":"5204_CR32","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00256-018-3086-2","volume":"48","author":"JR Soper","year":"2019","unstructured":"Soper JR, Bonar SF, O\u2019Sullivan DJ, McCredie J, Willert HG (2019) Thalidomide and neurotrophism. Skeletal Radiol 48(4):517\u2013525","journal-title":"Skeletal Radiol"},{"issue":"5","key":"5204_CR33","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.semarthrit.2017.09.010","volume":"47","author":"L Lu","year":"2018","unstructured":"Lu L, Shen M, Jiang D, Li Y, Zheng X, Li Y et al (2018) Blau syndrome with good reponses to tocilizumab: a case report and focused literature review. Semin Arthritis Rheum 47(5):727\u2013731","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"5204_CR34","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3899\/jrheum.160672","volume":"44","author":"T Nagakura","year":"2017","unstructured":"Nagakura T, Wakiguchi H, Kubota T, Yamatou T, Yamasaki Y, Nonaka Y et al (2017) Tumor necrosis factor inhibitors provide longterm clinical benefits in pediatric and young adult patients with Blau syndrome. J Rheumatol 44(4):536\u2013538","journal-title":"J Rheumatol"},{"issue":"11","key":"5204_CR35","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1136\/annrheumdis-2020-217320","volume":"79","author":"T Matsuda","year":"2020","unstructured":"Matsuda T, Kambe N, Ueki Y, Kanazawa N, Izawa K, Honda Y et al (2020) Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation. Ann Rheum Dis 79(11):1492\u20131499","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5204_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jaapos.2011.02.004","volume":"15","author":"VR Raiji","year":"2011","unstructured":"Raiji VR, Miller MM, Jung LK (2011) Uveitis in Blau syndrome from a de novo mutation of the NOD2\/CARD15 gene. J AAPOS 15(2):205\u2013207","journal-title":"J AAPOS"},{"issue":"5","key":"5204_CR37","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jaapos.2013.06.009","volume":"17","author":"L Bravo-Ljubetic","year":"2013","unstructured":"Bravo-Ljubetic L, Peralta-Calvo J, Noval S, Pastora-Salvador N, Abelairas-G\u00f3mez J, Merino R (2013) Adalimumab therapy for refractory childhood uveitis. J AAPOS 17(5):456\u2013459","journal-title":"J AAPOS"},{"issue":"2","key":"5204_CR38","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/art.37776","volume":"65","author":"G Simonini","year":"2013","unstructured":"Simonini G, Xu Z, Caputo R, De Libero C, Pagnini I, Pascual V et al (2013) Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. Arthritis Rheum 65(2):513\u2013518","journal-title":"Arthritis Rheum"},{"key":"5204_CR39","volume":"2011","author":"F Caracseghi","year":"2011","unstructured":"Caracseghi F, Izquierdo-Blasco J, Sanchez-Montanez A, Melendo-Perez S, Roig-Quilis M, Modesto C (2011) Etanercept-induced myelopathy in a pediatric case of blau syndrome. Case Rep Rheumatol 2011:134106","journal-title":"Case Rep Rheumatol"},{"issue":"2","key":"5204_CR40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/art.24222","volume":"60","author":"TM Martin","year":"2009","unstructured":"Martin TM, Zhang Z, Kurz P, Ros\u00e9 CD, Chen H, Lu H et al (2009) The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity. Arthritis Rheum 60(2):611\u2013618","journal-title":"Arthritis Rheum"},{"issue":"4","key":"5204_CR41","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ccm.2019.07.003","volume":"40","author":"MS Godfrey","year":"2019","unstructured":"Godfrey MS, Friedman LN (2019) Tuberculosis and biologic therapies: anti-tumor necrosis factor-\u03b1 and beyond. Clin Chest Med 40(4):721\u2013739","journal-title":"Clin Chest Med"},{"issue":"9","key":"5204_CR42","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1007\/s00431-022-04560-2","volume":"181","author":"F Barbati","year":"2022","unstructured":"Barbati F, Marrani E, Volpi B, Ferrara G, Lodi L, Mastrolia MV et al (2022) Mycophenolate mofetil-induced hypogammaglobulinemia and infectious disease susceptibility in pediatric patients with chronic rheumatic disorders: a monocentric retrospective study. Eur J Pediatr 181(9):3439\u20133448","journal-title":"Eur J Pediatr"},{"issue":"1","key":"5204_CR43","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12969-021-00634-x","volume":"19","author":"S Zhang","year":"2021","unstructured":"Zhang S, Cai Z, Mo X, Zeng H (2021) Tofacitinib effectiveness in Blau syndrome: a case series of Chinese paediatric patients. Pediatr Rheumatol Online J 19(1):160","journal-title":"Pediatr Rheumatol Online J"},{"issue":"11","key":"5204_CR44","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1002\/art.22966","volume":"56","author":"JI Ar\u00f3stegui","year":"2007","unstructured":"Ar\u00f3stegui JI, Arnal C, Merino R, Modesto C, Antonia Carballo M, Moreno P et al (2007) NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum 56(11):3805\u20133813","journal-title":"Arthritis Rheum"},{"key":"5204_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102152","volume":"42","author":"G Lopalco","year":"2020","unstructured":"Lopalco G, Schiraldi S, Venerito V, Guerriero S, Iannone F (2020) Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multiple sclerosis-associated uveitis. Mult Scler Relat Disord 42:102152","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"5204_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10067-016-3506-4","volume":"36","author":"C Fabiani","year":"2017","unstructured":"Fabiani C, Vitale A, Emmi G, Lopalco G, Vannozzi L, Guerriero S et al (2017) Interleukin (IL)-1 inhibition with anakinra and canakinumab in Beh\u00e7et\u2019s disease-related uveitis: a multicenter retrospective observational study. Clin Rheumatol 36(1):191\u2013197","journal-title":"Clin Rheumatol"},{"key":"5204_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.851453","volume":"10","author":"I Maccora","year":"2022","unstructured":"Maccora I, Abu Rumeileh S, Curci F, de Libero C, Marrani E, Mastrolia MV et al (2022) Tocilizumab and abatacept for the treatment of childhood chronic uveitis: a monocentric comparison experience. Front Pediatr 10:851453","journal-title":"Front Pediatr"},{"issue":"6","key":"5204_CR48","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40272-020-00422-2","volume":"22","author":"HI Brunner","year":"2020","unstructured":"Brunner HI, Wong R, Nys M, Kou TD, Dominique A, Martini A et al (2020) Abatacept: a review of the treatment of polyarticular-course juvenile idiopathic arthritis. Paediatr Drugs 22(6):653\u2013672","journal-title":"Paediatr Drugs"},{"issue":"7","key":"5204_CR49","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1136\/annrheumdis-2020-219012","volume":"80","author":"PG Traves","year":"2021","unstructured":"Traves PG, Murray B, Campigotto F, Galien R, Meng A, Di Paolo JA (2021) JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib. Ann Rheum Dis 80(7):865\u2013875","journal-title":"Ann Rheum Dis"},{"key":"5204_CR50","doi-asserted-by":"crossref","unstructured":"\u00c1lvarez-Reguera C, Prieto-Pe\u00f1a D, Herrero-Morant A, S\u00e1nchez-Bilbao L, Mart\u00edn-Varillas JL, Gonz\u00e1lez-L\u00f3pez E et al (2022) Clinical and immunological study of tofacitinib and baricitinib in refractory Blau syndrome: case report and literature review. Ther Adv Musculoskelet Dis 14:1759720X221093211","DOI":"10.1177\/1759720X221093211"},{"issue":"6","key":"5204_CR51","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/acr.23871","volume":"71","author":"ST Angeles-Han","year":"2019","unstructured":"Angeles-Han ST, Ringold S, Beukelman T, Lovell D, Cuello CA, Becker ML et al (2019) 2019 American College of Rheumatology\/Arthritis Foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res (Hoboken) 71(6):703\u2013716","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"5204_CR52","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/acr.24963","volume":"75","author":"I Foeldvari","year":"2023","unstructured":"Foeldvari I, Maccora I, Petrushkin H, Rahman N, Anton J, de Boer J et al (2023) New and updated recommendations for the treatment of juvenile idiopathic arthritis-associated uveitis and idiopathic chronic anterior uveitis. Arthritis Care Res (Hoboken) 75(5):975\u2013982","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-05204-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-023-05204-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-05204-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T06:02:45Z","timestamp":1707458565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-023-05204-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["5204"],"URL":"https:\/\/doi.org\/10.1007\/s00431-023-05204-9","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,22]]},"assertion":[{"value":"20 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}